Systemic Prevention and Management for Perioperative Hypothermia and Its Effect on Patients Outcome
Establishment of Systemic Prevention and Management for Perioperative Hypothermia and Its Effect on Patients Outcome-a Prospective Multiple Centers Randomized Controlled Study
1 other identifier
interventional
800
0 countries
N/A
Brief Summary
This is a randomized, single-blinded, multi-center study clinical trial to determine both clinical and health outcomes of stratified warm strategy to prevent intraoperative hypothermia. Participants enrolled into this trial will be from elective major surgery population in PUMC Hospital, Beijing Hospital and Xuanwu Hospital. investigators plan to enroll approximately 800 participants. Hypothermia risk will be evaluated through PREDICTOR model in all participants. According to hypothermia risk level, these participants will be stratefied into high, moderate and low risk group. Participants in each group will be randomly categorize into warm group and control group. Active warm and fluid warm strategy, prewarm and fluid warm strategy and only prewarm strategy are used for high risk, moderate risk and low risk patients seperately. For controll group traditional passive warm was used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2019
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2019
CompletedFirst Posted
Study publicly available on registry
March 18, 2019
CompletedStudy Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2021
CompletedMarch 18, 2019
March 1, 2019
2 years
March 13, 2019
March 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of intraoperative hypothermia
Core temperature\<36℃
During operation
Secondary Outcomes (13)
The amount of Intraoperative blood loss/blood transfusion
During operation
Length of stay in PACU
Postoperative during in postanaesthesia care unit, up to 24 hours after surgery
The incidence of Surgical site infection
WIthin 30 days postoperative
Lenght of Stay in hospital
impatient period, up to 6 month after surgery
Lenght of Stay in ICU
impatient period, up to 6 month after surgery
- +8 more secondary outcomes
Study Arms (2)
control group
SHAM COMPARATORCotton Blanket Warming (CBW) starts 30 min preoperatively and then continues throughout the entire operation.
warm group
EXPERIMENTALWarm according to different hypothermia risk for low risk ---Forced-air warming(FAW) starts at least 30 min preoperatively and then Cotton Blanket Warming (CBW) continues throughout the entire operation. moderate risk---Forced-air warming(FAW) starts at least 30 min preoperatively and then Cotton Blanket Warming (CBW) and fluid warming continues throughout the entire operation. high risk ----Forced-air warming(FAW) starts at least 30 min preoperatively, FAW and fluid warming continues throughout the entire operation.
Interventions
Bair HuggerTM Forced-air Warming System to 30min pre- and entire operation warming, combined fluid warming
30 min prewarming The Bair HuggerTM Forced-air Warming System cotton blanket warming and fluid warming through operation
30 min prewarming The Bair HuggerTM Forced-air Warming System and cotton blanket warming through operation
Eligibility Criteria
You may qualify if:
- Age≥18 Core temperature preoperation ≥36.0 ℃ and ≤37.5℃ ASA I-III Informed consent
You may not qualify if:
- emergency operation
- uncontrolled diebete mellitus with insulin treatment (preoperative blood glucose\>250mg/dL)
- hyperthyroidism and hypothyroidism
- Raynaud's disease
- patients with hematopathy and immune disease
- anticoagulant and non-steroid anti-inflammatory drug intake with 14 days before operation
- infectious fever within 4 weeks before operation
- laboratory abnomality as follow
- Hemoglobin≤10.0g/L
- Platelet≤100,000/ml
- White blood cell\<3000/dl or\>14,000/dl
- Fibrinogen\<200mg/dL
- Thrombin time\>40 second
- International normalized ratio\<70%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking Union Medical College Hospitallead
- Xuanwu Hospital, Beijingcollaborator
- Beijing Hospitalcollaborator
Related Publications (3)
Yi J, Xiang Z, Deng X, Fan T, Fu R, Geng W, Guo R, He N, Li C, Li L, Li M, Li T, Tian M, Wang G, Wang L, Wang T, Wu A, Wu D, Xue X, Xu M, Yang X, Yang Z, Yuan J, Zhao Q, Zhou G, Zuo M, Pan S, Zhan L, Yao M, Huang Y. Incidence of Inadvertent Intraoperative Hypothermia and Its Risk Factors in Patients Undergoing General Anesthesia in Beijing: A Prospective Regional Survey. PLoS One. 2015 Sep 11;10(9):e0136136. doi: 10.1371/journal.pone.0136136. eCollection 2015.
PMID: 26360773BACKGROUNDYi J, Zhan L, Lei Y, Xu S, Si Y, Li S, Xia Z, Shi Y, Gu X, Yu J, Xu G, Gu E, Yu Y, Chen Y, Jia H, Wang Y, Wang X, Chai X, Jin X, Chen J, Xu M, Xiong J, Wang G, Lu K, Yu W, Lei W, Qin Z, Xiang J, Li L, Yao M, Huang Y. Establishment and Validation of a Prediction Equation to Estimate Risk of Intraoperative Hypothermia in Patients Receiving General Anesthesia. Sci Rep. 2017 Oct 24;7(1):13927. doi: 10.1038/s41598-017-12997-x.
PMID: 29066717RESULTYi J, Lei Y, Xu S, Si Y, Li S, Xia Z, Shi Y, Gu X, Yu J, Xu G, Gu E, Yu Y, Chen Y, Jia H, Wang Y, Wang X, Chai X, Jin X, Chen J, Xu M, Xiong J, Wang G, Lu K, Yu W, Lei W, Qin Z, Xiang J, Li L, Xiang Z, Pan S, Zhan L, Qiu K, Yao M, Huang Y. Intraoperative hypothermia and its clinical outcomes in patients undergoing general anesthesia: National study in China. PLoS One. 2017 Jun 8;12(6):e0177221. doi: 10.1371/journal.pone.0177221. eCollection 2017.
PMID: 28594825RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yuguang Huang, doctor
Peking Union Medcial College Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice director
Study Record Dates
First Submitted
March 13, 2019
First Posted
March 18, 2019
Study Start
April 1, 2019
Primary Completion
March 31, 2021
Study Completion
August 31, 2021
Last Updated
March 18, 2019
Record last verified: 2019-03